Clinical Trial Update: PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 PK and safety study of HCP1303 and co-administration of HGP1201 and HIP1402 under fed conditions in healthy male volunteers; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Erectile Dysfunction

Drugs mentioned

• HCP1303
• HGP1201
• HIP1402

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Erectile Dysfunction, Prostatic Hyperplasia | Phase 1 | Status: COMPLETED